Avella Specialty Pharmacy Named One of Inc. 5000's Fastest Growing Companies for 10th Straight Year

Article

Avella Specialty Pharmacy has again been designated one of Inc. Magazine's 5,000 fastest growing companies in America.

PRESS RELEASE August 17, 2016 Phoenix, AZ -- Avella Specialty Pharmacy has again been designated one of Inc. Magazine’s 5,000 fastest growing companies in America. Avella has received this honor every year over the last decade, starting with the inception of the magazine’s original list in 2006. This year, Avella reached #3,048 on the Inc. 5000 based on its 3-year growth rate of 112 percent, meaning that the company has more than doubled its revenue since 2012.

“Avella is in a unique position in that we’re able to achieve this impressive level of growth while still maintaining a service-oriented culture that promotes patient health and engagement,” said Rebecca M. Shanahan, CEO. “We are truly proud to receive this recognition and to be joined by some of the most forward-thinking companies across a wide variety of sectors.”

Inc. identified companies for this year’s list by measuring growth from 2012 to 2015. To qualify for inclusion on the list, companies must be U.S.-based, privately held, for-profit and independent (i.e., not subsidiaries or divisions of other companies) as of Dec. 31, 2015. For complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, visit

inc.com/profile/avella-specialty-pharmacy

.

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit:  JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.